News Overview

Reliance Jio Infocomm, a leading telecom provider, announced a 13% year-on-year increase in standalone net profit to ₹5,337 Crore for the quarter ended March 31, 2024.

According to IQVIA MAT data, Mirabegron extended-release tablets (USP 25mg and 50mg) had yearly sales of USD 2.42 billion in the United States.

The company's gross sales for FY24 was ₹3,06,786 Crore, up 17.8% from the previous year.

Only employees with office compliance levels more than 85% will get the entire variable pay for the quarter.

The broader market outperformed the benchmark indices, with the BSE SmallCap index gaining 0.91% and the BSE MidCap index rising 0.46%.

Awfis Space Solutions' IPO includes a fresh issue of ₹160 Crore and an offer-for-sale of up to 10.02 million shares by existing shareholders and promoters.

The project encompasses both the supply and service aspects for its development on a turnkey basis and is expected to be completed within the financial year 2024-25.

The company plans to utilize the net proceeds from the issue to finance its working capital requirements and general corporate purposes.

Earlier reports from Reuters had highlighted SEBI's findings of rule violations by listed entities and breaches of offshore fund holdings limits in August last year.

In FY24, Jio witnessed a substantial 12% annual growth in net profit, reaching ₹21,423 Crore, compared to ₹19,124 Crore in FY23.